[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Rallybio Corporaton (RLYB)

Rallybio Corporaton (RLYB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 84,611
  • Shares Outstanding, K 5,298
  • Annual Sales, $ 860 K
  • Annual Income, $ -8,980 K
  • EBIT $ -32 M
  • EBITDA $ -33 M
  • 60-Month Beta -0.88
  • Price/Sales 98.31
  • Price/Cash Flow N/A
  • Price/Book 1.68

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year $-1.76
  • Growth Rate Est. (year over year) +56,861.36%

Price Performance

See More
Period Period Low Period High Performance
1-Month
13.80 +15.72%
on 05/19/26
17.57 -9.13%
on 06/01/26
+1.87 (+13.26%)
since 05/18/26
3-Month
7.90 +102.15%
on 03/30/26
17.57 -9.13%
on 06/01/26
+6.61 (+70.62%)
since 03/18/26
52-Week
2.40 +565.42%
on 06/23/25
17.57 -9.13%
on 06/01/26
+13.36 (+512.16%)
since 06/18/25

Most Recent Stories

More News
Are SUNE, RLYB, ASRT, TMHC Obtaining Fair Deals for their Shareholders?

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.

TMHC : 71.58 (-0.01%)
RLYB : 15.97 (+0.31%)
ASRT : 23.50 (+0.09%)
SUNE : 2.55 (-6.93%)
Rallybio Investor Alert: Kahn Swick & Foti, LLC Investigates Merger of Rallybio Corporation - RLYB

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Rallybio Corporation (NasdaqCM:...

RLYB : 15.97 (+0.31%)
Shareholder Alert: Ademi LLP investigates whether Rallybio Corporation is obtaining a Fair Price for Public Shareholders

MILWAUKEE , June 2, 2026 /PRNewswire/ -- Ademi LLP is investigating Rallybio (Nasdaq: RLY) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction...

RLYB : 15.97 (+0.31%)
RLY : 35.37 (-0.37%)
RLYB Stock Alert: Halper Sadeh LLC is Investigating Whether Rallybio Corporation is Obtaining a Fair Price for its Shareholders

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transaction may contain terms that could limit superior...

RLYB : 15.97 (+0.31%)
Rallybio Corporation and Avenzo Therapeutics Announce Merger Agreement to Advance Next-Generation Oncology Therapies and $215 Million Concurrent Private Placement

Combined company to operate as Avenzo Therapeutics, advancing a leading portfolio of next-generation oncology therapies, including small molecules and antibody-drug conjugates ...

RLYB : 15.97 (+0.31%)
Are WSR, TERN, RLYB, DAWN Obtaining Fair Deals for their Shareholders?

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.

RLYB : 15.97 (+0.31%)
WSR : 18.95 (+0.16%)
TERN : 52.95 (+0.04%)
DAWN : 21.53 (+0.19%)
Are EWCZ, STEL, RLYB, CTRA Obtaining Fair Deals for their Shareholders?

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.

RLYB : 15.97 (+0.31%)
EWCZ : 5.82 (+0.34%)
STEL : 38.43 (+0.39%)
CTRA : 32.56 (-8.62%)
Rallybio Investor Alert: Kahn Swick & Foti, LLC Investigates Merger of Rallybio Corporation - RLYB

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Rallybio Corporation (NasdaqCM:...

RLYB : 15.97 (+0.31%)
Are KW, AES, RLYB Obtaining Fair Deals for their Shareholders?

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.

RLYB : 15.97 (+0.31%)
KW : 10.92 (-0.09%)
AES : 14.62 (+0.07%)

Business Summary

Rallybio Corporation is a clinical-stage biotechnology company committed to identifying and accelerating the development of therapies for patients with severe and rare diseases. Rallybio Corporation is headquartered in New Haven, Connecticut.

See More

Key Turning Points

3rd Resistance Point 16.64
2nd Resistance Point 16.44
1st Resistance Point 16.20
Last Price 15.97
1st Support Level 15.76
2nd Support Level 15.56
3rd Support Level 15.32

See More

52-Week High 17.57
Last Price 15.97
Fibonacci 61.8% 11.78
Fibonacci 50% 9.99
Fibonacci 38.2% 8.20
52-Week Low 2.40

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.